FBR Capital Starts Quest Diagnostics (DGX) at Market Perform
Tweet Send to a Friend
FBR Capital initiates coverage on Quest Diagnostics (NYSE: DGX) with a Market Perform. PT $68.00.
Analyst Tom Gallucci comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst Tom Gallucci comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE